NCT04180800

Brief Summary

Social isolation among elderly people is a frequent and major determinant for health. The risk of premature death is 2 to 5 time higher for socially isolated people, similarly for morbidity, duration of healing and complications rate. Denutrition is also frequent for elderly people with potentially serious consequences. Vitamin deficiency, especially in B9 and B12 vitamins, are often associated with denutrition among elderly people. Folic acid (vitamin B9) is not influenced by inflammation and folic acid income are necessarily exogene. Vitamin B9 is provided by fresh fruits and vegetables, and giblets. The investigators observed a high prevalence in folic acid deficiency for socially isolated elderly patients. The investigators made the hypothesis that a folic acid defiency is associated with social isolation for elderly people. The primary purpose is the study of the association between folic acid deficiency (measured by dosing of plasma concentration of vitamin B9) and social isolation evaluated by Lubben Social Network Scale in 6 questions. The secondary purposes are the study of the correlation between folic acid deficiency and social conditions, nutritional status, biological data, poly pharmacy, cognitive functions, dependency and length of stay at hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 29, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

January 23, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 13, 2020

Completed
Last Updated

September 24, 2020

Status Verified

October 1, 2019

Enrollment Period

Same day

First QC Date

October 1, 2019

Last Update Submit

September 22, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Measure of plasma concentration on vitamin B9 by blood test taken in regular hospital admission

    Folic acid deficiency is evaluated by dosing of plasma concentration of vitamin B9 through blood test taken in regular hospital admission. Folic acid deficiency is defined by a concentration under 3 ng/mL.

    10 weeks

  • Measure of social isolation by Lubben Social Network Scale in 6 questions

    Social isolation is measured by score results on LSNS-6 auto-survey. A score lower than 12/30 is associated with social isolation.

    10 weeks

Study Arms (2)

Folic acid deficiency

Those with a folic acid defiency

Other: Lubben Social Network Scale - 6

No deficiency

Those with no folic acid deficiency

Other: Lubben Social Network Scale - 6

Interventions

One short oral interview to complete the Lubben Social Network Scale in auto-survey, translated in French. It contains 6 questions on 30 points, higher scores are associated with more social engagement, lower scores, specifically under 12/30, are associated with social isolation.

Folic acid deficiencyNo deficiency

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients over 75 years old, hospitalized in geriatric rehabilitation care in Strasbourg University Hospital

You may qualify if:

  • Patients hospitalized in geriatric rehabilitation care in Strasbourg University Hospital
  • Age \> 75 years
  • Patient has given his consent

You may not qualify if:

  • Digestive malabsorption disorder : gastrectomy, extended intestinal resection, Crohn disease, celiac disease, parenteral nutrition
  • Chronic alcoholism
  • Treatment with sulfamids, methotrexate, anti epileptic treatment (hydantoin)
  • Hemodialysis
  • Patients under protection measure (curatorship, guardianship, judicial protection)
  • Patient refuses to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Les Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location

MeSH Terms

Conditions

Folic Acid DeficiencySocial Isolation

Condition Hierarchy (Ancestors)

Vitamin B DeficiencyAvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic DiseasesSocial BehaviorBehavior

Study Officials

  • Catherine JEHL

    Les Hôpitaux Universitaires de Strasbourg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2019

First Posted

November 29, 2019

Study Start

January 23, 2020

Primary Completion

January 23, 2020

Study Completion

August 13, 2020

Last Updated

September 24, 2020

Record last verified: 2019-10

Locations